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Abstract
Background: The prevalence of dog erythrocyte antigen (DEA 1) in canine population is approximately 40–60%.
Often data are limited to a small number of breeds and/or dogs. The aims of this study were to evaluate frequency
of DEA 1 in a large population of purebred and mongrel dogs including Italian native breeds and to recognize a
possible association between DEA 1 and breed, sex, and genetic and phenotypical/functional classifications of
breeds. Frequencies of DEA 1 blood group collected from screened/enrolled blood donors and from healthy and
sick dogs were retrospectively evaluated. The breed and the sex were recorded when available. DEA 1 blood typing
was assessed by immunocromatographic test on K3EDTA blood samples. The prevalence of DEA 1 antigen was
statistically related to breed, gender, Fédération Cynologique Internationale (FCI) and genotypic grouping.
Results: Sixty-two per cent dogs resulted DEA 1+ and 38% DEA 1-. DEA 1- was statistically associated with Dogo
Argentino, Dobermann, German Shepherd, Boxer, Corso dogs, the molossian dogs, the FCI group 1, 2 and 3 and
the genetic groups “working dogs” and “mastiff”. DEA 1+ was statistically associated with Rottweiler, Briquet Griffon
Vendéen, Bernese mountain dog, Golden Retriever, the hunting breeds, the FCI group 4, 6, 7 and 8 and the genetic
groups “scent hounds” and “retrievers”. No gender association was observed.
Conclusions: Data obtained by this work may be clinically useful to drive blood donor enrollment and selection
among different breeds.
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Background
Blood groups are defined according to antigenic and
species-specific genetic markers localized on the surface
of erythrocyte cell membranes [1, 2]. Canine blood groups
have received international standardization and were clas-
sified using the acronym DEA (dog erythrocyte antigen)
followed by a number [2–5]. Historically, DEA 1 system
included the types DEA 1.1 and DEA 1.2 (and possibly
DEA 1.3) [2, 5]. Virtually, all DEAs can induce alloanti-
body formation but the most immunogenic antigen
seemed to be DEA 1.1 [2, 4]. Recently, the DEA 1 blood
group system has been described as a complex autosomal
dominant allelic system with varied surface antigen ex-
pression levels [7–9]. Then, a dog could be classified as
DEA 1 negative (DEA 1-) or DEA 1 positive (DEA 1+)
with weak to strong antigen expression [7, 8]. The propor-
tion of DEA 1- and strong DEA 1+ dogs were recently re-
ported to be far larger than those of weak and moderate
DEA 1+ dogs [9].
Antigens other than DEA were discovered in dogs, i.e.
Dal [10–12], Kai 1 and Kai 2 [9].
The canine blood typing for the red blood cell antigens,
other than DEA 1, can be done only by a laboratory. In
clinical practice, for in-house canine blood group DEA 1
determination, commercial point-of-care typing tests i.e.
typing cards and immunochromatographic strips, using
murine monoclonal anti-DEA 1 antibodies, are available
[7, 13–15].
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The general prevalence of DEA 1 in canine population
is approximately 40–60% [9, 16–18]. Information about
frequency of DEA 1+ and DEA 1- blood group between
breeds is available but often involved a limited number of
breeds. Data have been reported in Japan [19], Brazil [17,
20], South Africa [21], Nigeria [22], Croatia [23, 24], US
[16, 25], Portugal [26], Turkey [6], Spain [18], India [27],
Switzerland [28], Romania [29] and North America [9].
The aims of this study were (1) to evaluate frequency
of DEA 1 in a large population of purebred and mongrel
dogs including Italian native breeds and (2) to recognize
a possible association between DEA 1+ and DEA 1-
blood groups and breed, sex and genetic and phenotyp-
ical/functional breed grouping.
Methods
Dogs, samples and DEA 1 antigen assessment
This is a cross-sectional study without an “a priori” def-
inition of the sample. It includes data collected from
January 2013 to December 2015 and obtained from dogs
screened and/or enrolled as blood donors and from
healthy or sick dogs evaluated during clinical activity.
DEA 1 blood typing and breed were available in all the
dogs, and sex in the majority of the cases. Data were
obtained from the Canine Blood Bank at the Istituto
Zooprofilattico Sperimentale delle Venezie (Padua, Italy)
(n = 354), the Department of Veterinary Medicine, Unit
of Transfusion Medicine at the University of Perugia
(Italy) (n = 313), the Veterinary Laboratory “San Marco”
(Padua, Italy) (n = 242) and the Department of Veterin-
ary Medicine at the University of Milan (Italy) (n = 128).
Blood was collected from cephalic or jugular vein into
K3EDTA tubes, stored at 4–6 °C and processed within
24 h of collection. DEA 1 blood group was determined
using an immunochromatographic strip typing kit (Labt-
est DEA 1, Alvedia, Limonest, France) according to the
manufacturer’s instructions. Based on the test results,
the dogs were classified as DEA 1+ and DEA 1–. For
DEA 1+ dogs the band strength was not assessed.
Statistical analysis
The differences of DEA 1 prevalence in relation to sex
and breed were tested by chi-square test or Fisher’s exact
test when appropriate. Data of the breeds represented by
at least 15 dogs were used for breed statistical analysis
referred to frequencies. Moreover for breed comparison,
dogs were grouped following different criteria: i) based
on Fédération Cynologique Internationale (FCI, http://
www.fci.be/en/) breed classification (10 groups); ii) based
on genetic grouping (10 groups) as reported by von-
Holdt et al. (2010); iii) breeds with hunting function in-
cluded in FCI group 6 (Scent hounds and related
breeds), 7 (Pointing dog) and 8 (Retrievers-Flushing
dogs-Water dogs) compared to non-hunting breeds; iv)
molossian dogs belonging to both FCI group 2 (Pincher
and Schnauzer-Molossoid breeds-Swiss Mountain and
Cattle dogs) and group 9 (Companion and Toy dogs)
compared to non-molossian dogs.
The Italian Maremma hound breed was not classified
in a FCI group but it was considered as a hunting breed
for statistical analysis.
Chi-square value, P value, odds ratios (OR) and their
95% confidence interval (95% CI) were calculated for
each comparison made. In case of zero value, a unity
was added to each number in the calculation of the ORs.
The mongrels group was chosen as the reference group.
For data concerning FCI and genetic group classification,
every group was compared with the others and not with
the mixed breed dogs.
Statistical analyses were performed using the freely
available online software WinEpi 2.0 (http://www.wine-
pi.net/uk/index.htm) [30]. Values of p < 0.01 were con-
sidered significant.
Results
In the present study, 1037 dogs were evaluated. They
were mongrels (n = 205) and purebred (n = 832), male
(n = 498) and female (n = 523). The sex was unknown
for 16 dogs. Purebred dogs belonged to 88 breeds.
Thirty-eight percent (396/1037) of all the dogs tested
DEA 1- and 62% (641/1037) DEA 1+. The percentages
remained the same considering the mongrel and purebred
subgroups. Dogs belonging to 14 breeds were statistically
analyzed. In Tables 1 and 2 the frequencies of DEA 1- and
DEA 1+ dogs according to breed and subjected to statis-
tical analysis were summarized and related to data avail-
able in literature (when referred at least to 15 dogs per
breed). In Table 3 were reported the frequencies related to
breeds not subjected to statistical analysis. DEA 1- blood
group was observed in all the Dogo Argentino and in
mostly Dobermann, German Shepherd, Boxer and Corso
dogs. All Rottweiler, Dachshound, Italian Maremma
hound, Grand bleu de Gascogne, Anglo-français de petit
vénierie and mostly Briquet Griffon Vendéen, Bernese
mountain dog, English Setter, Giura hound, Golden Re-
triever, Labrador Retriever, Pinscher/Zwergpinscher and
Ariégeois dogs resulted DEA 1 + .
No difference in the prevalence of DEA 1 antigen was
observed in relation to gender (p: 0.21, chi- square: 1.58,
OR: 0.843, 95% CI: 0.65–1.09).
Data about DEA 1 frequency of dogs (n = 79) belong-
ing to an Italian breeds are reported in Tables 1, 2 and 3.
The hunting dogs (n = 392, breeds n = 33) resulted
statistically associated with DEA 1+ (81%; p < 0.01, chi-
square: 121.92, OR: 5.54, 95% CI: 4.04–7.60). The molos-
sian dogs (n = 158, breeds n = 16) resulted statistically as-
sociated with DEA 1- (67%; p < 0.01, chi-square: 68.18,
OR: 4.41, 95% CI: 3.05–6.38).
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All purebred dogs were classified based on FCI groups
and dogs belonging to 42 breeds (n = 468) were classified
according to the genetic groups proposed by vonHoldt
et al. (2010). Based on FCI classification dogs belonging
to groups 1 “Sheepdogs and cattledogs, except swiss cat-
tledogs” (72/89, 81%), 2 “Pinscher and Schnauzer-
Molossoid and swiss mountain and cattledogs” (136/254,
53%) and 3 “Terriers” (18/30, 60%) were more likely to
be DEA 1- (p < 0.01). Dogs belonging to groups 4
“Dachshunds” (11/11, 100%), 6 “Scent hounds and re-
lated breeds” (129/157, 82%), 7 “Pointing dogs” (51/60,
85%), and 8 “Retrievers – Flushing dogs – Water dogs”
(131/167, 78%) were more likely DEA 1+ (p < 0.01).
Dogs belonging to genetic groups “working dogs” (77/
91, 85%) and “mastiff-like” (36/51, 71%) were signifi-
cantly more likely to be DEA 1- (p < 0.01) while dogs be-
longing to genetic groups “scent hounds” (47/51, 92%)
and “retrievers” (152/191, 80%) were significantly more
likely to be DEA 1+ (p < 0.01).
Discussion
The present study reports data about DEA 1 frequency
obtained from a large canine population including pure-
bred dogs belonging to 88 breeds and tested with a com-
mercial immunochromatographic kit. Few reports are
available on breed-specific DEA 1 frequencies, often in-
volving a limited number of dogs and breeds. They were
reported in Japan [19], Brazil [17, 20], South Africa [21],
Portugal [26], Spain [18, 31, 32], Switzerland [28] and
India [27]. A large survey of dogs has been performed in
the US but the detailed results were not published [17].
The DEA 1 antigen was present in the 62% of the dogs
included in this study without difference between mon-
grel and purebred subgroups. In agreement with our re-
sults, canine population frequencies range between 53%
in Switzerland [28] and 61% in Brazil [17]. In contrast,
lower percentages are reported in US (42%) [16] and
Japan (44%) [19]. In mongrels, inhomogeneous results
are published, with DEA 1+ dogs ranging from 48 [21]
to 90% [20].
Considering breed-specific frequency results, DEA 1-
group was statistically associated with Dogo Argentino,
Dobermann, German shepherd, Boxer and Corso dogs.
Frequencies obtained agree with those previously re-
ported (Table 1). Only for German Shepherd dogs fre-
quencies of 100% and 70% of DEA 1+ were reported in
Brazil [20] and India [27] respectively.
DEA 1+ blood group resulted statistically associated
with Rottweiler, Briquet Griffon Vendéen, Bernese
mountain dog and Golden Retriever breeds. Moreover
dogs belonging to English setter, Labrador Retriever, and
Ariégeois resulted prevalently DEA 1+ with frequencies
ranging from 73 to 94%. Our results were in agreement
with data reported elsewhere for Golden retriever [17]
Table 1 Frequency of DEA 1– blood type in breeds including15 dogs, statistical analysis results and summary of published data**
Breed n° of dogs % DEA 1- P value Chi-square OR 95% CI for OR % DEA 1- and location in literature
Dogo Argentino 56 100 <0.01* 93.08 12.63–686.15 95 B1
Dobermann 17 94 < 0.01 20.63 26.60 3.46–204.55 Data referred to groups <15 dogs
German Shepherds 65 92 < 0.01 59.18 19.95 7.67–51.84 90 B1; 84 SA; 30 I; 0 B2
Boxer 22 82 < 0.01 15.99 7.48 2.44–22.92 Data referred to groups <15 dogs
Corso dog 31 68 <0.01 10.10 3.49 1.56–7.80 71 It
*calculated by Fisher’s exact test, **only data obtained from breed with ≥15 dogs were reported
B1 Brazil, [17]; B2 Brazil, [20]; I India, [27]; It Italy [38]; J Japan, [19]; P Portugal, [26]; S Switzerland, [28]; SA South Africa: [21]
Table 2 Frequency of DEA 1+ blood type in breeds including at least 15 dogs, statistical analysis results and summary of published
data**
Breed n° of dogs % DEA 1+ P value Chi-square OR 95% CI for OR % DEA 1+ and location in literature
Rottweiler 15 100 <0.01* 9.02 1.17–69.67 100 B1; 88P; 86 B2; 78 SA
Bernese Mountain dog 50 94 < 0.01 18.6 9.4 2.84–31.32 100 S
Briquet Griffon Vendéen 32 94 < 0.01 12.21 9.02 2.10–38.82 None
English setter 21 86 0.03 4.51 3.61 1.03–12.65 53 J
Golden Retriever 77 83 < 0.01 11.01 2.96 1.53–5.73 95 B1
Labrador Retriever 69 77 0.03 4.76 1.99 1.06–3.73 87 I; 55 SA; 45 P
Ariegeois 55 73 0.16 2.01 1.60 0.83–3.09 None
Newfoundland 21 62 0.96 0.02 0.98 0.39–2.46 None
Italian short/rough-haired hound 16 62 0.99 0 1.00 0.35–2.87 None
*calculated by Fisher’s exact test; **only data obtained from breed with ≥15 dogs were reported
B1 Brazil, [17]; B2 Brazil, [20]; I India, [27]; J Japan, [19]; P Portugal, [26]; S Switzerland, [28]; SA South Africa: [21]
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and Bernese mountain dog [28]. Our Rottweiler were
100% DEA 1+ as reported in Brazil [17], even if else-
where 12–22% of DEA 1- dogs were described [20, 21].
To the best of our knowledge, this is the first data about
DEA 1 frequency for Briquet Griffon Vendéen, and
Ariégeois. More extensive surveys would be strongly re-
quired to confirm the results of the present work, espe-
cially for breeds represented by a low number of dogs.
The discrepancies observed in our frequencies referred to
mongrel and some purebred dogs compared to other stud-
ies could be related to the geographical different expression
of the antigen as previously hypothesized [26, 33]. The per-
formance of the diverse DEA 1 blood typing tests used in
the different works published worldwide, may be also con-
sidered as a possible explanation. Even though no currently
accepted gold standard for DEA 1 blood typing is available
[14], the kit used in the present work seems to have the bet-
ter performance. In fact when compared with other
methods (i.e. card agglutination assay or gel-based method),
it resulted specific and less subjective than the sensitive typ-
ing cards [15]. Moreover, recent flow cytometric typing
studies demonstrated a significant correlation with chroma-
tographic strips for DEA 1 assessment, using the same
monoclonal anti DEA 1 antibody [7, 8]. A possible limita-
tion of the present study may be that only one blood typing
method was used both in healthy and sick animals. Since it
is a retrospective study, no information about the presence
and the severity of anemia of ill dogs are available. The re-
duction of PCV has been reported to cause a decrease in
the intensity of the DEA 1 band. [15, 34]. Consequently, in
our survey a limited number of false negative results could
not be excluded. Studies including dogs of different geo-
graphical area, obtained with the same test and, possibly,
with the band straight assessment should be helpful to re-
duce influences (i.e few breeders, dogs closely related, test
performance) on DEA 1 frequency referred to breed.
The FCI nomenclature splits purebred dog into ten
groups based on morphology, current use and historical
criteria. Recently, genetic diversity of dog breeds was
evaluated and surprisingly a correspondence between
genetic and phenotypical/functional breed grouping was
observed with some exception [35]. Dogs were accur-
ately assigned to their breed >99% of the time [35] and
the various breeds related one to another [35]. Related
groups of breed were defined by these studies and a cor-
relation with breed genetic relatedness, morphological
features and geographic origin was observed [36, 37].
Dogs belonging to our database were classified based on
FCI groups and genetic groups involving breeds that
clustered together as previously reported [35]. Remark-
ably dogs belonging to FCI groups 1 and 2 resulted sta-
tistically more likely to be DEA 1- and dogs belonging
to groups 4, 6, 7, 8 resulted more likely to be DEA 1+.
In addition dogs belonging to genetic groups “working
dogs” and “mastiff-like” resulted more likely DEA 1- and
the groups “scent hounds” and “retriever” were more
likely DEA 1+ .
Furthermore, molossoid dogs resulted statistically as-
sociated to DEA 1- blood group while dogs belonging to
Table 3 Frequency of DEA 1+ and DEA 1 – blood types in
breeds not statistically analyzed
Breed Dogs (n) DEA 1+ (%) DEA 1– (%)
Cocker Spaniel 14 57 43
Border Collie 13 38 62
Anglo français de petite venerie 12 100 0
Giura Hound 12 83 17
Pinscher/Zwergpinscher 12 75 25
Dachshound 11 100 0
Jack Russel Terrier 10 50 50
Italian pointing dog 8 75 25
Gran Bleu de Gascogne 8 100 0
Italian Maremma hound 8 100 0
Yorkshire Terrier 8 68 32
Poodle 7 100 0
Beagle 7 71 29
Kurzhaar 7 86 14
Bullmastiff 7 71 29
Weimaraner 7 71 29
American Staffordshire 5 20 80
Bouledogue francais 5 20 80
Great dane 5 80 20
Cavalier King Charles spaniel 5 80 20
Epagneul Breton 5 100 0
Maremma and Abruzzes sheepdog 5 100 0
Posavatz hound 5 100 0
English Bulldog 4 0 100
West Highland White Terrier 4 25 75
Pug 4 100 0
Maltese 4 75 25
Italian pointer 4 100 0
Rhodesian Ridgeback 4 100 0
Pomeranian Spitz/Volpino italiano 4 75 25
Other prevalently DEA 1+ * 49 86 14
Other prevalently DEA 1-** 22 8 92
*Afgan hound, Akita inu, Alaskan Malamute, Anatolian shepherd, Basset
hound, Bavarian hound, Beauceron, Bergamasco shepherd, Bolognese,
Caucasian shepherd, Chihuahua, Clumber spaniel, Dalmatian, Galgo espagnol,
Irish setter, Italian greyhound, Korthal, Langharr, Leonberger, Petit bleu de
Gascogne, Romagna water dog, Saint Bernard dog, Samoiedo, Schnauzer,
Shar-pei, Shiba inu, Spinone, Springer spaniel
**Bichon a poil frise, Bichon Havanas, Black and tan coonhound, Bobtail,
Boston terrier, Bull terrier, Dogue de Bordeaux, Drahataar, Flat coated, Fox
terrier, Greyhound, Saluki, Scottish shepherd, Shitzu, Siberian Husky, Black
russian terrier
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hunting breeds were significantly associated with DEA 1
+ blood group. More data have to be collected to con-
firm this observation.
Frequency of only DEA 1 antigen was studied in the
present work. Extended canine blood groups assessment
including DEA other than 1 should be performed on
candidate blood donor but it was not easily available for
clinicians. In the clinical practice only DEA 1 kits are
commercially available and could be used before the
transfusion to test donor and recipient. Consequently
the resulted reported in the present large canine popula-
tion study could be exploited by clinicians to choose the
most suitable dog to test in order to find the right candi-
date blood donor quickly.
Conclusion
The present study provides data on the frequency of
DEA 1 antigen in a large number of dogs and confirms a
broad variability among breeds. In fact, some breeds
show high frequency of DEA 1- subjects resulting more
susceptible to immunization when they receive blood
from an incompatible donor.
In the routine activity of clinicians and of canine blood
bank, our results may be valuable to drive blood donor
enrollment and selection among different breeds.
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